SecBot SecBot
SECBOTREPLAY Home › Report › APGE

APGE · Two top insiders (CEO and CMO) sold a total of $14.1M in open-market…

Apogee Therapeutics, Inc. · CLUSTER filed Jun 24, 2026 at 20:01 ET

At the news

NEUTRALIMPACT 6/10

CLUSTER filed Jun 24, 2026 at 20:01 ET

Two top insiders (CEO and CMO) sold a total of $14.1M in open-market transactions on June 22, 2026, just days after the company announced a merger agreement with AbbVie. The sales represent 0.14% of market cap and are likely routine monetization ahead of the deal close, but the timing draws attention.

  • CEO Michael Thomas Henderson sold 80,000 shares at $132.54 (~$10.6M) on June 22.
  • CMO Carl Dambkowski sold 26,400 shares at $132.60 (~$3.5M) on June 22.
  • Total insider sales of $14.1M represent 0.14% of APGE's $10B market cap.
  • Sales occurred 4 days after the June 18 merger agreement with AbbVie (via Andor entities).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access